γ9δ2 T-Cell Expansion and Phenotypic Profile Are Reflected in the CDR3δ Repertoire of Healthy Adults.

Autor: Vyborova A; Center for Translational Immunology, University Medical Center (UMC) Utrecht, Utrecht University, Utrecht, Netherlands., Janssen A; Center for Translational Immunology, University Medical Center (UMC) Utrecht, Utrecht University, Utrecht, Netherlands., Gatti L; Center for Translational Immunology, University Medical Center (UMC) Utrecht, Utrecht University, Utrecht, Netherlands., Karaiskaki F; Center for Translational Immunology, University Medical Center (UMC) Utrecht, Utrecht University, Utrecht, Netherlands., Yonika A; Center for Translational Immunology, University Medical Center (UMC) Utrecht, Utrecht University, Utrecht, Netherlands., van Dooremalen S; Center for Translational Immunology, University Medical Center (UMC) Utrecht, Utrecht University, Utrecht, Netherlands., Sanders J; Center for Translational Immunology, University Medical Center (UMC) Utrecht, Utrecht University, Utrecht, Netherlands., Beringer DX; Center for Translational Immunology, University Medical Center (UMC) Utrecht, Utrecht University, Utrecht, Netherlands., Straetemans T; Center for Translational Immunology, University Medical Center (UMC) Utrecht, Utrecht University, Utrecht, Netherlands.; Department of Hematology, University Medical Center (UMC) Utrecht, Utrecht University, Utrecht, Netherlands., Sebestyen Z; Center for Translational Immunology, University Medical Center (UMC) Utrecht, Utrecht University, Utrecht, Netherlands., Kuball J; Center for Translational Immunology, University Medical Center (UMC) Utrecht, Utrecht University, Utrecht, Netherlands.; Department of Hematology, University Medical Center (UMC) Utrecht, Utrecht University, Utrecht, Netherlands.

Publikováno v: Frontiers in immunology [Front Immunol] 2022 Jul 07; Vol. 13, pp. 915366. Date of Electronic Publication: 2022 Jul 07 (Print Publication: 2022).

Efficacy of MSC for steroid-refractory acute GVHD associates with MSC donor age and a defined molecular profile.

Autor: van der Wagen LE; Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Miranda-Bedate A; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Janssen A; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Fernando F; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Appukudige N; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., van Dooremalen S; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Westinga K; Cell Therapy Facility, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Admiraal R; Pediatric Blood and Marrow Transplant Program Prinses Maxima Centre for Pediatric Oncology, Utrecht, the Netherlands., Lorenowicz MJ; Center for Molecular Medicine and Regenerative Medicine Center UMC Utrecht, Utrecht University, Utrecht, the Netherlands., Huls G; Department of Hematology, UMC Groningen, Groningen, the Netherlands., Janssen JJWM; Department of Hematology, Amsterdam University Medical Centers, loc. VUmc Amsterdam, Amsterdam, the Netherlands., Broers AEC; Department of Hematology, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands., van der Velden WJFM; Department of Hematology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands., van Marwijk Kooy R; Department of Internal Medicine, Isala klinieken Zwolle, Zwolle, the Netherlands., Hazenberg MD; Department of Hematology, Academic Medical Center Amsterdam, Amsterdam, the Netherlands., de Haar C; Cell Therapy Facility, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Lindemans C; Department of Hematology, Princess Maxima Centrum, Utrecht, the Netherlands., Jan Boelens J; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Department of Pediatrics, Stem Cell Transplant and Cellular Therapies Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kuball J; Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. J.H.E.Kuball@umcutrecht.nl.; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. J.H.E.Kuball@umcutrecht.nl.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2020 Nov; Vol. 55 (11), pp. 2188-2192. Date of Electronic Publication: 2020 Apr 28.

γδ T-cell Receptors Derived from Breast Cancer-Infiltrating T Lymphocytes Mediate Antitumor Reactivity.

Autor: Janssen A; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Villacorta Hidalgo J; Institute for Surgical Pathology, University Medical Center, University of Freiburg, Freiburg, Germany.; Faculty of Biology, University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany., Beringer DX; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., van Dooremalen S; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Fernando F; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., van Diest E; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Terrizi AR; Institute for Surgical Pathology, University Medical Center, University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany., Bronsert P; Institute for Surgical Pathology, University Medical Center, University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK) and Cancer Research Center (DKFZ), Heidelberg, Germany.; Comprehensive Cancer Center Freiburg, Medical Center - University of Freiburg, Freiburg, Germany., Kock S; Institute for Surgical Pathology, University Medical Center, University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany., Schmitt-Gräff A; Institute for Surgical Pathology, University Medical Center, University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany., Werner M; Institute for Surgical Pathology, University Medical Center, University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK) and Cancer Research Center (DKFZ), Heidelberg, Germany.; Comprehensive Cancer Center Freiburg, Medical Center - University of Freiburg, Freiburg, Germany., Heise K; Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Essen, Germany., Follo M; Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Straetemans T; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Sebestyen Z; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Chudakov DM; Privolzhsky Research Medical University, Nizhny Novgorod, Russia.; Center for Data-Intensive Biomedicine and Biotechnology, Skolkovo Institute of Science and Technology, Moscow, Russia.; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia., Kasatskaya SA; Center for Data-Intensive Biomedicine and Biotechnology, Skolkovo Institute of Science and Technology, Moscow, Russia.; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia., Frenkel FE; BostonGene LLC, Lincoln, Nebraska., Ravens S; Institute of Immunology, Hannover Medical School, Hannover, Germany., Spierings E; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Prinz I; Institute of Immunology, Hannover Medical School, Hannover, Germany., Küppers R; Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Essen, Germany., Malkovsky M; UW School of Medicine and Public Health, Madison, Wisconsin., Fisch P; Institute for Surgical Pathology, University Medical Center, University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany., Kuball J; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. j.h.e.kuball@umcutrecht.nl.; Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Publikováno v: Cancer immunology research [Cancer Immunol Res] 2020 Apr; Vol. 8 (4), pp. 530-543. Date of Electronic Publication: 2020 Feb 04.

Anti-HER2 Cancer-Specific mAb, H 2 Mab-250-hG 1 , Possesses Higher Complement-Dependent Cytotoxicity than Trastuzumab.

Autor: Suzuki, Hiroyuki¹ (AUTHOR) hiroyuki.suzuki.b4@tohoku.ac.jp, Ohishi, Tomokazu^2,3 (AUTHOR) ohishit@bikaken.or.jp, Tanaka, Tomohiro¹ (AUTHOR) tomohiro.tanaka.b5@tohoku.ac.jp, Kaneko, Mika K.¹ (AUTHOR) mika.kaneko.d4@tohoku.ac.jp, Kato, Yukinari¹ (AUTHOR) yukinari.kato.e6@tohoku.ac.jp

Publikováno v: International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 15, p8386. 15p.

P854: HEXABODY‐CD38 INDUCES TROGOCYTOSIS AND EFFECTIVELY INDUCES COMPLEMENT‐MEDIATED TUMOR CELL LYSIS AFTER TREATMENT WITH DARATUMUMAB OR ISATUXIMAB IN VITRO.

Autor: Hiemstra, I. H., Santegoets, K., Janmaat, M. L., Ten Hagen, W., Van Dooremalen, S., De Goeij, B. E., Bosgra, S., Sasser, A. K., Breij, E. C.

Publikováno v: HemaSphere; 2022 Supplement 3, Vol. 6, p747-748, 2p